BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36641044)

  • 1. Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by α-flupenthixol.
    Carney AE; Clarke C; Pratt WE
    Neurosci Lett; 2023 Feb; 797():137069. PubMed ID: 36641044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine.
    Brown CM; Fletcher PJ; Coscina DV
    Peptides; 1998; 19(10):1667-73. PubMed ID: 9880070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing.
    Ito R; Hayen A
    J Neurosci; 2011 Apr; 31(16):6001-7. PubMed ID: 21508225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbic substrates of the effects of neuropeptide Y on intake of and motivation for palatable food.
    Pandit R; Luijendijk MC; Vanderschuren LJ; la Fleur SE; Adan RA
    Obesity (Silver Spring); 2014 May; 22(5):1216-9. PubMed ID: 24500791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting motivational states: The effects of nucleus accumbens dopamine and opioid receptor activation on a modified effort-based choice task.
    Carlson HN; Murphy C; Pratt WE
    Behav Brain Res; 2021 Feb; 399():112999. PubMed ID: 33161034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of memory consolidation by the basolateral amygdala or nucleus accumbens shell requires concurrent dopamine receptor activation in both brain regions.
    LaLumiere RT; Nawar EM; McGaugh JL
    Learn Mem; 2005; 12(3):296-301. PubMed ID: 15930508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjections of flupenthixol into the caudate-putamen but not the nucleus accumbens, amygdala or frontal cortex of rats produce intra-session declines in food-rewarded operant responding.
    Beninger RJ; Ranaldi R
    Behav Brain Res; 1993 Jun; 55(2):203-12. PubMed ID: 8395180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preadolescent dopamine receptor antagonism increases postadolescent reward-related operant behaviors that may depend on dopamine receptor hypersensitivity.
    Holahan MR; Goheen K
    Neurosci Lett; 2020 Apr; 725():134917. PubMed ID: 32200030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct contributions of dopamine receptors in the nucleus accumbens core or shell to established cocaine reinforcement under a second-order schedule.
    Di Ciano P
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):888-96. PubMed ID: 18760571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task.
    Robbins TW; Giardini V; Jones GH; Reading P; Sahakian BJ
    Behav Brain Res; 1990 May; 38(3):243-61. PubMed ID: 2114120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward.
    Fletcher PJ; Higgins GA
    Psychopharmacology (Berl); 1997 Nov; 134(1):64-72. PubMed ID: 9399368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats.
    Moore E; Merali Z; Beninger RJ
    Pharmacol Biochem Behav; 1994 Jul; 48(3):681-8. PubMed ID: 7938123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption.
    Nowend KL; Arizzi M; Carlson BB; Salamone JD
    Pharmacol Biochem Behav; 2001; 69(3-4):373-82. PubMed ID: 11509194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens and dorsal medial striatal dopamine and neural activity are essential for action sequence performance.
    Fraser KM; Chen BJ; Janak PH
    Eur J Neurosci; 2024 Jan; 59(2):220-237. PubMed ID: 38093522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of testosterone conditioned place preference is blocked by peripheral or intra-accumbens injection of alpha-flupenthixol.
    Packard MG; Schroeder JP; Alexander GM
    Horm Behav; 1998 Aug; 34(1):39-47. PubMed ID: 9735227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
    Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens.
    Ebner SR; Roitman MF; Potter DN; Rachlin AB; Chartoff EH
    Psychopharmacology (Berl); 2010 Jun; 210(2):241-52. PubMed ID: 20372879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens.
    Obuchowicz E; Turchan J
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):329-35. PubMed ID: 10422894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y system in accumbens shell mediates ethanol self-administration in posterior ventral tegmental area.
    Borkar CD; Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
    Addict Biol; 2016 Jul; 21(4):766-75. PubMed ID: 25929272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.